Background illustration for clinical trials search

Paid Clinical Trials Bloomfield Hills

Discover 1,707 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

for
Multiple Sclerosis
Location: Farmington Hills MI, Columbus OH, Northbrook IL,
Sponsor: Sanofi

Sex: All

Age: 18 - 60

Code: NCT07325292

Phase3, Recruiting

Growth Hormone Replacement Therapy for Retried Professional Football Players

for
TBI (Traumatic Brain Injury), Concussion, Brain, Sport Injury,
Location: Dearborn MI
Sponsor: Center for Neurological Studies

Sex: Male

Age: 18 - 70+

Code: NCT04121780

Phase2, Recruiting

Registry for Stage 2 Type 1 Diabetes

for
Type 1 Diabetes
Location: Farmington Hills MI, Ann Arbor MI, Cleveland OH,
Sponsor: Sanofi

Sex: All

Age: 0+

Code: NCT06481904

Recruiting

Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

for
Respiratory Syncytial Virus Immunization,
Location: Southfield MI, Farmington Hills MI, Beachwood OH,
Sponsor: Sanofi

Sex: All

Age: 60+

Code: NCT07734649

Phase1, Phase2, Recruiting

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

for
Geographic Atrophy (GA),
Location: Royal Oak MI, Ann Arbor MI, London, Cleveland OH,
Sponsor: ONL Therapeutics

Sex: All

Age: 55+

Code: NCT06659445

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Lung EpiCheck Biomarkers Development Study

for
Lung Cancer
Location: Troy MI, Panama City FL, Shreveport LA, Miami FL,
Sponsor: Nucleix Ltd.

Sex: All

Age: 20 - 70+

Code: NCT06245876

Recruiting

A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Troy MI, Columbus OH, Pittsburgh PA, Lisle IL,
Sponsor: Syncromune, Inc.

Sex: Male

Age: 18+

Code: NCT06533644

Phase2, Recruiting

Alleviant ALLAY-HF Study

for
Heart Failure
Location: Ann Arbor MI, Toledo OH, Cleveland OH, Newmarket,
Sponsor: Alleviant Medical, Inc.

Sex: All

Age: 40+

Code: NCT05685303

Recruiting

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

for
Bladder Cancer
Location: Troy MI, Cleveland OH, Jeffersonville IN, Syracuse NY,
Sponsor: Arquer Diagnostics Ltd

Sex: All

Age: 22+

Code: NCT05508568

Recruiting

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

for
Immune Thrombocytopenia
Location: Ann Arbor MI, Rochester MN, Albany NY, The Bronx NY,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07007962

Phase3, Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms

for
Benign Prostatic Hyperplasia
Location: Troy MI, Lisle IL, New York NY, Syosset NY, Raleigh NC,
Sponsor: Rivermark Medical

Sex: Male

Age: 45+

Code: NCT06849258

Recruiting

Are Superficial Parasternal Intercostal Plane (SPIP) Blocks With Bupivacaine and With or Without Adjuvants Helpful for Post-operative Pain After Coronary Artery Bypass Grafting?

for
Post-operative Pain Management
Location: Pontiac MI
Sponsor: Wayne State University

Sex: All

Age: 18 - 70+

Code: NCT05003765

Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Madison Heights MI, Ann Arbor MI, Waterloo, Guelph,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase3, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Allen Park MI, Windsor, Brighton MI, Toledo OH,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190222

Phase3, Recruiting

Are Adductor Canal Blocks With Bupivacaine and Added Magnesium Better at Managing Post-operative Pain Than Bupivacaine and Added Buprenorphine in Patients Undergoing Same-day Discharge Total Knee Arthroplasty?

for
Post-operative Pain, Acute, Opioid Use
Location: Pontiac MI
Sponsor: Wayne State University

Sex: All

Age: 18 - 70+

Code: NCT05091138

Recruiting
Active & Responsive

A Study of YL201 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Detroit MI, Ann Arbor MI, Brampton, Toronto, Fairfax VA,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05434234

Phase1, Phase2, Recruiting
Active & Responsive

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

for
Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome,
Location: Detroit MI, Columbus OH, Chicago IL,
Sponsor: Procyrion

Sex: All

Age: 21+

Code: NCT05677100

Not recruiting
Featured

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

for
Hidradenitis Suppurativa, Atopic Dermatitis
Location: Ann Arbor MI, Sacramento CA
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06524635

Phase2, Recruiting

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

for
Autoimmune Haemolytic Anaemia
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Columbus OH,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07086976

Phase3, Recruiting
Featured

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia
Location: Detroit MI, Cleveland OH, Dyer IN, Morgantown WV,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase3, Recruiting